AKASA Named One of the Top Healthcare Technology Companies of 2026

South San Francisco, Calif. — July 7, 2026 — AKASA, the leading provider of generative AI solutions for the healthcare revenue cycle, has been named one of the Top Healthcare Technology Companies of 2026 by the Healthcare Technology Report.

The annual list recognizes healthcare technology companies that are improving how care is delivered, managed, and financed. AKASA was recognized for its work applying AI to the revenue cycle, helping health systems improve accuracy and strengthen clinical documentation and coding.

“The most meaningful healthcare technology companies are not chasing novelty,” said Malinka Walaliyadde, CEO and co-founder of AKASA. “They’re solving the friction points that determine whether the system can function. We’re honored to be included on this list because AKASA is focused on one of the most important of those points: helping health systems accurately capture and communicate the care they deliver.”

This latest recognition follows continued momentum for AKASA, including its exponential growth, work with leading health systems, and recognition as a top revenue cycle AI company.

About AKASA

AKASA is the leading provider of generative AI for health systems, helping organizations capture the full value of the care they deliver. AKASA applies AI across the revenue cycle to review patient encounters, surface clinical documentation and coding opportunities, and improve accuracy, reimbursement, quality capture, and operational efficiency.

Unlike rules-based tools or sampled reviews, AKASA builds a custom large language model for each health system, trained on its clinical data, workflows, and documentation patterns. This allows AKASA to capture the nuance of each organization and deliver greater accuracy and efficiency.

AKASA partners with leading health systems, including Cleveland Clinic, where its work has been recognized as “one of the most comprehensive real-world uses of GenAI in healthcare finance.”